Mast Therapeutics, Inc. (MSTX)

[lecorb]

Analyst Ratings Network:Price Target: $2.10 (255.93% upside)

Ratings Breakdown: 1 Sell Rating(s), 4 Buy Rating(s)
Consensus Rating: Buy (Score: 2.60)
Consensus Price Target: $2.10 (255.93% upside)


9/16/2014 Piper Jaffray Reiterated Rating Overweight $1.00 -> $1.20
9/8/2014 Laidlaw Reiterated Rating Buy
8/6/2014 Laidlaw Initiated Coverage Buy $2.50
6/16/2014 ISI Group Initiated Coverage Reduce
10/3/2013 Canaccord Genuity Initiated Coverage Reduce -> Buy $3.00
10/3/2013 Cantor Fitzgerald Initiated Coverage Buy
6/25/2013 Piper Jaffray Initiated Coverage Overweight
4/2/2013 JMP Securities Initiated Coverage Outperform $2.00